Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by Rotalucepson May 18, 2022 5:28pm
214 Views
Post# 34693770

Less revenue than a year ago, put Financials above quarterly

Less revenue than a year ago, put Financials above quarterly
Since the Canadian ones all have the same problem, too many competitors, they promise crumb like EBITDA instead of real probfit. They need big fat profit.  0.48 millions more than the previous quarter? The population will not double so the Canadian companies will stall for a long time. My advice, stay on the side until the Senate vote before the August recess. On a positive vote, I am a buyer. I will play the news until it lasted. 

Quarterly

                                       Dec 21     Sep 21    Jun 21      Mar 21 Dec 20
Total Revenue 60.59 60.11 54.61 55.16 67.67

Annual 
                                       Jun 21 Jun 20 Jun 19 Jun 18     Jun 17
Total Revenue                245.25 268.70 245.54 55.20 18.07

<< Previous
Bullboard Posts
Next >>